EPIRUS Biopharmaceuticals, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906

Attached files

file	filename
10-K - FORM 10-K - EPIRUS Biopharmaceuticals, Inc.	d10k.htm
EX-21.1 - LIST OF SUBSIDIARIES - EPIRUS Biopharmaceuticals, Inc.	dex211.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - EPIRUS Biopharmaceuticals, Inc.	dex231.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.	dex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.	dex311.htm
EX-10.54 - SUB-LEASE RENEWAL AND AMENDMENT AGREEMENT - EPIRUS Biopharmaceuticals, Inc.	dex1054.htm
EX-10.56 - SECOND AMENDMENT TO LEASE AGREEMENT - EPIRUS Biopharmaceuticals, Inc.	dex1056.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of CombinatoRx, Incorporated (the “Company”), do hereby certify that to their knowledge:

1) the Company’s Form 10-K for the fiscal year ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the Company’s Form 10-K for the fiscal year ended December 31, 2009 fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/ MARK H.N. CORRIGAN

Mark H.N. Corrigan

President and Chief Executive Officer

(principal executive officer)

/S/ JUSTIN A. RENZ

Justin A. Renz

Senior Vice President and Chief Financial Officer

(principal financial and accounting officer)

Dated: March 26, 2010

Attached files

Stock widget

Investing forum

EPIRUS Biopharmaceuticals, Inc. Reports